Login to Your Account



Transcelerate Biopharma starts newco to explore preclinical toxicology data

By Michael Fitzhugh
Staff Writer

Wednesday, February 10, 2016

Transcelerate Biopharma Inc., a nonprofit established by 10 of the industry's largest pharmas in 2012, is launching Biocelerate, a new subsidiary that aims to improve efficiencies in preclinical research, first by working to illuminate the relationship between patient response and preclinical toxicology findings.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription